Tina Ho, MD, PhD
Associate Program Director, Atopic Dermatitis Center; Attending Physician, Dermatology Program; Director of Clinical and Translational Research
Instructor of Dermatology, Harvard Medical School
Image
Tina Ho, MD, PhD
Associate Program Director, Atopic Dermatitis Center; Attending Physician, Dermatology Program; Director of Clinical and Translational Research
Instructor of Dermatology, Harvard Medical School
Medical Services
Education
Undergraduate School
Yale University
2009
New Haven
CT
Graduate School
University of Pennsylvania
2015
Philadelphia
PA
Medical School
University of Pennsylvania
2017
Philadelphia
PA
Internship
Pediatrics
Children's Hospital of Philadelphia
2018
Philadelphia
PA
Residency
Dermatology
University of Cincinnati
2021
Cincinnati
OH
Fellowship
Pediatric Dermatology
Boston Children's Hospital
2022
Boston
MA
Publications
Continuous Subcutaneous Insulin Infusion (CSII)-Associated Granulomatous Suppurative Reaction in Four Children With Type 1 Diabetes. View Abstract
Validation of the atopic dermatitis control tool in pediatric patients with atopic dermatitis. View Abstract
Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross-Sectional Study. View Abstract
Corrigendum to 'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology' [Annals of Allergy, Asthma & Immunology 133/3 (2024) 286-94]. View Abstract
Medicaid coverage for nonsteroidal topical atopic dermatitis treatment is often restrictive and variable across the United States. View Abstract
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology. View Abstract
Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis. View Abstract
Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10. View Abstract
Urticaria in infants: A single-institution retrospective study. View Abstract
Warts in pediatric oncology patients: A single-institution retrospective study. View Abstract
Most common pediatric skin conditions managed in outpatient dermatology clinics in the United States stratified by race and ethnicity. View Abstract
Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders. View Abstract
Trends in coal tar use in the United States. View Abstract
SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation. View Abstract
The enigma and challenges of vitiligo pathophysiology and treatment. View Abstract
A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses. View Abstract
Clinical course of porokeratosis ptychotropica over 7 years in an otherwise healthy child. View Abstract
Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-?B and mitogen-activated protein kinase pathways. View Abstract
Gallic Acid Induces Apoptosis in Human Gastric Adenocarcinoma Cells. View Abstract
Cutaneous Small-Vessel Vasculitis in Two Children with Inflammatory Bowel Disease: Case Series and Review of the Literature. View Abstract
Including Langerhans cell histiocytosis in the differential diagnosis of skin tumors with osteoclast-like multinucleated giant cells. View Abstract
The Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation. View Abstract
NK cell lytic granules are highly motile at the immunological synapse and require F-actin for post-degranulation persistence. View Abstract
Mutagenesis identifies the critical amino acid residues of human endonuclease G involved in catalysis, magnesium coordination, and substrate specificity. View Abstract
Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter. View Abstract